Proximie
Proximie is a health technology platform that enables surgeons to virtually attend operating theaters to visually guide complex surgeries.
$80M Series B+ ·
Led by Advent Life Sciences · Source: startupintros.com
Latest round on record: Series B+, September 2024, amount undisclosed.
Total raised: $118M across 2 sourced rounds
All 3 rounds ↓Signals
Proximie | 1883 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
- Series B+ · amount undisclosedSource: fundraisingfox.com
- Series B+ · $80M
AAdvent Life Sciences (lead),
BBritish Patient Capital,
EEight Roads Ventures,
EEmerson Collective,
FF-Prime Capital,
GGlobal Ventures,
MMaverick Ventures,
MMinderoo Foundation,
MMubadala Capital Ventures,
QQuesta Capital Management,
SSoftBank Vision Fund
Source: startupintros.com - Series B+ · $38M
EEight Roads Ventures (lead),
FF-Prime Capital (lead),
MMaverick Ventures (lead),
QQuesta Capital Management (lead),
BBECO Capital,
CCedar Mundi Ventures,
GGlobal Ventures
Source: startupintros.com - X account created
- Website created
Founders and team
NH
Nadine Hachach-Haram FounderRC
Richard Carter CTOBD
Bryn Davies Global Marketing OfficerDH
David Herrmann Chief Growth OfficerDN
Davide Nocentini General Manager Europe & ANZEC
Ed Cardiff Head of Strategic ProjectsOB
Oleg Bodiul CFO
Investors
AAdvent Life Scienceslead investor
AAWS Healthcare Accelerator
BBECO Capital
BBritish Patient Capital
CCedar Mundi Ventures
EEight Roads Ventureslead investor
EEmerson Collective
FF-Prime Capitallead investor
GGlobal Ventures
MMaverick Ventureslead investor
MMinderoo Foundation
MMubadala Capital Ventures
QQuesta Capital Managementlead investor
SSoftBank Vision Fund
Companies like Proximie
AAugmeditSeed · Nov 2022MMMI$125M Series B+ · Oct 2026
OOrthofuse$2.98M Seed · Feb 2026PPanda Surgical
BBaton$10M Series A · Jan 2025
SSaint Raphael HealthSeed · May 2026
Other companies backed by Advent Life Sciences
TT-Therapeutics$133M Series B+ · Nov 2026
GGlycomine$115M Series B+ · May 2025
EEpitopea$31M Series A · Oct 2024
FF2G$100M Series B+ · Sep 2024
AArgá Medtech$58.72M Series B+ · Feb 2024
Advent Life Sciences portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/proximie (get a free API key).